Mereo BioPharma (MREO) Revenue (2023 - 2025)
Mereo BioPharma's (MREO) quarterly Revenue came in at $500000.0 in Q2 2025, down 50.0% on a QoQ basis from $1.0 million in Q4 2023.
Mereo BioPharma (MREO) Revenue (2023 - 2025) Analysis & Trends
Mereo BioPharma (MREO) has 2 years of Revenue data on file, last reported at $500000.0 in Q2 2025.
- On a quarterly basis, Revenue changed N/A year-over-year to $500000.0 in Q2 2025; TTM through Dec 2025 was $500000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $500000.0, changed N/A from the prior year.
- Revenue for Q2 2025 stood at $500000.0, down from $1.0 million in the prior quarter.
- Over the last five years, Revenue for MREO reached as high as $9.0 million in Q2 2023 and fell as low as $500000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Mereo BioPharma | 229.80 Mn | 229.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 500,000.00 |
| Dec 31, 2023 | 1.00 Mn |
| Jun 30, 2023 | 9.00 Mn |